Company Filing History:
3 out of 5 
2 out of 1,863 
1 out of 1 Years Active: 2022-2025
Title: The Innovative Contributions of Daniel J Byrd
Introduction
Daniel J Byrd is a prominent inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative work on oncolytic viruses. With a total of 6 patents to his name, Byrd's inventions are paving the way for advancements in cancer treatment.
Latest Patents
One of Byrd's latest patents is focused on oncolytic immunotherapy by tumor micro-environment remodeling. This patent discloses modified oncolytic viruses that include modifications in the viral genome encoding exogenous nucleic acids. These modifications aim to enhance oncolytic immunotherapy by remodeling the tumor microenvironment and improving systemic delivery. Another notable patent is for a platform oncolytic vector for systemic delivery. This disclosure provides a modified oncolytic virus that can contain modifications in the viral genome and exogenous nucleic acids coding for proteins, serving as a platform vector for systemic delivery.
Career Highlights
Throughout his career, Daniel J Byrd has worked with notable organizations such as Kalivir Immunotherapeutics, Inc. and the University of Pittsburgh. His work in these institutions has allowed him to collaborate with other experts in the field and further his research in immunotherapy.
Collaborations
Byrd has collaborated with esteemed colleagues, including Stephen Howard Thorne and Mingrui Zhang. These partnerships have contributed to the advancement of his research and the development of innovative therapies.
Conclusion
Daniel J Byrd's contributions to the field of immunotherapy through his patents and collaborations highlight his role as a leading inventor. His work continues to influence the landscape of cancer treatment and showcases the importance of innovation in medical research.